Hyperbaric Oxygen Therapy (HBOT)
Hyperbaric Oxygen Therapy (HBOT) is an intervention with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
80.0%
8 of 10 finished
20.0%
2 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)
Effect of Hyperoxygenated Environment on Maximal Muscle Strength
Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance
Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS
Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications
Clinical Trials (13)
Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)
Effect of Hyperoxygenated Environment on Maximal Muscle Strength
Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance
Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS
Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications
SNM vs. HBOT for Refractory IC/BPS
Effectiveness of Hyperbaric Oxygen Therapy in Adults
Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia
Hyperbaric Oxygen Treatment in Autism Spectrum Disorders
Hyperbaric Oxygen for COVID-19 Patients
Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine
The Effect of Hyperbaric Oxygen Therapy on Patients Suffering From Neurologic Deficiency Due Traumatic Brain Injury
Hyperbaric Oxygen Therapy Induced Neuroplasticity in Post Stroke Patients Suffering Chronic Neurological Deficiencies
All 13 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 13